Cat. No.: X24-08-YM374
Cytochrome P450 inhibitor, Deferasirox, Purity ≥98%
Synonym: 201530-41-8; ICL-670; ICL-670A; CGP-72670; 4-[3,5-Bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid
- MDL: MFCD09751362
- CAS Number: 201530-41-8
- Compound CID: 214348
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Properties
Description
Deferasirox, soluble in DMSO and ethanol and insoluble in water, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting cytochrome P450.
Molecular Formula
C21H15N3O4
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 64 mg/mL (171.42 mM); Water: insoluble; Ethanol: 2 mg/mL; In vivo: 5% DMSO + 40% PEG 300 + 5% Tween 80 + 50% H2O, 3.5 mg/mL
Applications
Deferasirox is a metabolism inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of chronic iron overload due to conditions such as thalassemia or sideroblastic anemia, often resulting from repeated blood transfusions.
Related Products
-
Cytochrome P450 inhibitor, Abiraterone, Purity ≥98%
-
Cytochrome P450 inhibitor, Alizarin, Purity ≥98%
-
Cytochrome P450 inhibitor, Apigenin, Purity ≥98%
-
Cytochrome P450 inhibitor, Avasimibe, Purity ≥98%
-
Cytochrome P450 inhibitor, Baicalein, Purity ≥98%
-
Metabolism inhibitor, Chloramphenicol, Purity ≥98%
Quick Links
